Case number 1:17-cv-01868
OSI Pharmaceuticals, LLC et al v. Accord Healthcare Inc., USA > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 1, 2018 | 13 | Patent/Trademark Report to Commissioner (1) |
| Jun 1, 2018 | 13 | Stipulation of dismissal (2) |
| Jun 1, 2018 | 13 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (Attachments: # (1) Stipulation of dismissal)(mdb) |
| May 30, 2018 | 12 | SO ORDERED (2) Docket Text: SO ORDERED - re [11] Stipulation of Dismissal filed by Genentech, Inc., OSI Pharmaceuticals, LLC. Signed by Judge Gregory M. Sleet on 5/30/2018. ***Civil Case Terminated*** (mdb) |
| May 23, 2018 | 11 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Consent Order of Dismissal by Genentech, Inc., OSI Pharmaceuticals, LLC. (Fahnestock, Derek) Modified on 5/24/2018 (mdb). |
| Mar 20, 2018 | N/A | SO ORDERED (0) |
| Mar 15, 2018 | 10 | Stipulation to EXTEND Time (1) Docket Text: Joint STIPULATION TO EXTEND TIME to Move, Answer or Otherwise Respond to the Complaint to May 29, 2018 - filed by Accord Healthcare Inc., USA. (Ormerod, Eve) |
| Jan 29, 2018 | N/A | SO ORDERED (0) |
| Jan 24, 2018 | 9 | Motion for Leave to Appear Pro Hac Vice (8) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Amy K. Wigmore, Amanda L. Major and Tracey C. Allen, Emily R. Whelan and Kevin M. Yurkerwich of WILMER CUTLER PICKERING HALE AND DORR LLP - filed by Genentech, Inc., OSI Pharmaceuticals, LLC. (Fahnestock, Derek) |
| Jan 10, 2018 | N/A | SO ORDERED (0) |
| Jan 5, 2018 | 7 | Summons Returned Executed (1) Docket Text: SUMMONS Returned Executed by OSI Pharmaceuticals, LLC, Genentech, Inc.. Accord Healthcare Inc., USA served on 1/5/2018, answer due 1/26/2018. (Fahnestock, Derek) |
| Jan 5, 2018 | 8 | Stipulation to EXTEND Time (1) Docket Text: Joint STIPULATION TO EXTEND TIME for Defendant to move, answer or otherwise respond to Plaintiffs' Complaint to March 27, 2018 - filed by Genentech, Inc., OSI Pharmaceuticals, LLC. (Fahnestock, Derek) |
| Jan 3, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Gregory M. Sleet. Please include the initials of the Judge (GMS) after the case number on all documents filed. (rjb) |
| Dec 28, 2017 | 1 | Complaint (7) |
| Dec 28, 2017 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Accord Healthcare Inc., USA on 12/28/2017. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmfn) |
| Dec 28, 2017 | 1 | Exhibits A-B (48) |
| Dec 28, 2017 | 1 | Civil Cover Sheet (1) |
| Dec 28, 2017 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmfn) |
| Dec 28, 2017 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 11/20/2017. Date of Expiration of Patent: 5/9/2021.Thirty Month Stay Deadline: 5/20/2020. (nmfn) |
| Dec 28, 2017 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,900,221 B1. (nmfn) |
| Dec 28, 2017 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Astellas US LLC, Corporate Parent Astellas Pharma Inc., Corporate Parent Astellas US Holding, Inc. for OSI Pharmaceuticals, LLC filed by OSI Pharmaceuticals, LLC. (nmfn) |
| Dec 28, 2017 | 6 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Roche Holding Ltd., Corporate Parent Novartis Ltd., Corporate Parent Roche Holdings, Inc. for Genentech, Inc. filed by Genentech, Inc. (nmfn) |
| Dec 28, 2017 | 1 | Main Document (7) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Accord Healthcare Inc., USA - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2292166.) - filed by OSI Pharmaceuticals, LLC, Genentech, Inc. (Attachments: # (1) Exhibits A-B, # (2) Civil Cover Sheet)(nmfn) |
| Dec 28, 2017 | 1 | Complaint* (1) |
